Welcome to the monthly FibroHUB, the last one of the year 2024!
10 December at 15-16
Place: Lecture hall F202 (Aapistie 5B)
Topic:
by Daniel Ungureanu:
Setting scRNA-seq technologies for understanding tissue heterogeneity and drug responses
Daniela’s
team recently made a scientific breakthrough with their paper in Nature Chemical Biology, which has
immediately received a lot of media attention.
A multiplex single-cell RNA-Seq pharmacotranscriptomics
pipeline for drug discovery.
Dini A, Barker H, Piki E, Sharma S, Raivola J,
Murumägi A, Ungureanu D. Nat Chem Biol. 2024 Oct 31. doi: 10.1038/s41589-024-01761-8. Online ahead of print.PMID: 39482470
Brief intro to the topic: Single-cell RNA sequencing (scRNA-seq) has become a powerful tool for understanding tissue heterogeneity by profiling
gene expression at the single-cell level. This allows for the detection of rare cell types, uncovering cellular diversity, and identifying the molecular signatures of different cell populations and the way these cells respond to perturbations. There are several
scRNA-seq technologies that are particularly valuable for exploring transcriptomics at single cell levels. Come to find out!
Coffee/Tea or Glögi (first come, first serve), casual get-together, timely topic and discussions for community-building
and cross-disciplinary dialogue
--------------
-
Feel free to forward this invitation to your colleagues at the University of Oulu who could be interested to join and
register as a new FibroHealth researcher.
Cheers,
Ritva
----------------------------------------------------------------------------------------------------------
Ritva Saastamoinen
PhD, Adjunct Professor (Docent)
Coordinator, Profi6 Fibrobesity
Research Unit of Biomedicine and Internal Medicine (Room S5 230 at University Hospital)
Faculty of Medicine
University of Oulu
tel. +358 294 48 5226, +358 50 592 3333
X: FibroHealthOulu
@FibroOulu
&
@saastamoiritva
LinkedIn: FibroHealth Oulu
&
Ritva Saastamoinen
FibroHealth - Combatting Fibrosis in Chronic
Diseases | University of Oulu
FibroHealth Symposium 2024:
Bridge over Obesity – From Science to Practice
